<?xml version="1.0" encoding="UTF-8"?>
<ref id="B87">
 <label>87</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Esbenshade</surname>
    <given-names>T. A.</given-names>
   </name>
   <name>
    <surname>Browman</surname>
    <given-names>K. E.</given-names>
   </name>
   <name>
    <surname>Bitner</surname>
    <given-names>R. S.</given-names>
   </name>
   <name>
    <surname>Strakhova</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Cowart</surname>
    <given-names>M. D.</given-names>
   </name>
   <name>
    <surname>Brioni</surname>
    <given-names>J. D.</given-names>
   </name>
  </person-group>
  <article-title>The histamine H3 receptor: an attractive target for the treatment of cognitive disorders</article-title>
  <source>
   <italic toggle="yes">British Journal of Pharmacology</italic>
  </source>
  <year>2008</year>
  <volume>154</volume>
  <issue>6</issue>
  <fpage>1166</fpage>
  <lpage>1181</lpage>
  <pub-id pub-id-type="doi">10.1038/bjp.2008.147</pub-id>
  <pub-id pub-id-type="other">2-s2.0-47249148399</pub-id>
  <?supplied-pmid 18469850?>
  <pub-id pub-id-type="pmid">18469850</pub-id>
 </element-citation>
</ref>
